| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.460 | None | 1.000 | 3 | 2 | 2005 | 2019 | ||||||||
|
Pvt1 oncogene | 0.495 | 0.731 |
|
disease | 0.400 | None | 1.000 | 4 | 3 | 2010 | 2017 | |||||||||
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1999 | 2017 | ||||||||
|
POU class 2 homeobox associating factor 1 | 0.608 | 0.615 | 0.57 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2001 | 2018 | ||||||||
|
transcription factor 3 | 0.476 | 0.846 | 2.6E-02 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 1990 | 2014 | ||||||||
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2002 | 2017 | ||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2010 | 2014 | |||||||||
|
GATA3 antisense RNA 1 | 0.931 | 0.192 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2013 | |||||||||
|
long intergenic non-protein coding RNA 1185 | 0.743 | 0.346 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2013 | |||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2017 | 2017 | ||||||||
|
T helper type 2 locus control region associated RNA | 0.751 | 0.385 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2012 | 2014 | |||||||||
|
non-SMC condensin II complex subunit H2 | 0.805 | 0.385 | 2.9E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
HBS1 like translational GTPase | 0.705 | 0.462 | 1.9E-07 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
calsyntenin 2 | 0.716 | 0.423 | 3.5E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
SP140 nuclear body protein | 0.691 | 0.577 | 5.0E-08 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
BCL2 antagonist/killer 1 | 0.555 | 0.769 | 7.4E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
nuclear receptor coactivator 5 | 0.631 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
GRAM domain containing 1B | 0.736 | 0.385 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
acyl-CoA oxidase like | 0.674 | 0.577 | 5.2E-15 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
unc-51 like kinase 4 | 0.722 | 0.385 | 4.4E-38 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
calcium and integrin binding family member 3 | 0.839 | 0.154 | 2.3E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
dystrobrevin beta | 0.805 | 0.308 | 2.8E-10 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
MIR4435-2 host gene | 0.604 | 0.692 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
NCK adaptor protein 1 | 0.638 | 0.500 | 2.1E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
gametogenetin binding protein 1 (pseudogene) | 0.769 | 0.462 | 0.69 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 |